Skip to main content
. 2010 Aug;35(8 Section 2):2–4.

TABLE 8.

Treatment Differences: Pain (Healthy Subjects)

Variable Comparison Difference* Two-sided 90% CI (P value)
Maximum pain (mm) IgPro16 (15 mL) – Vivaglobin®
IgPro20 (15 mL) – Vivaglobin®
IgPro20 (12 mL) – Vivaglobin®
−2.54
−1.64
−2.43
−4.82, −0.26 (P=.0679)
−3.92, 0.64 (P=.2340)
−4.71, −0.15 (P=.0801)
Mean pain (mm) IgPro16 (15 mL) – Vivaglobin®
IgPro20 (15 mL) – Vivaglobin®
IgPro20 (12 mL) – Vivaglobin®
−1.41
−0.94
−1.54
−2.50, −0.33 (P=.0328)
−2.02, 0.15 (P=.1545)
−2.62, −0.46 (P=.0205)
*

A negative difference indicates a generally higher value of maximum/mean pain under Vivaglobin®.

Pain was assessed by subjects on a 100-mm VAS; numbers given are from that scale.

Source: Adapted from Hagan 2010.